First Trust NASDAQ Cybersecurity ETF (NASDAQ: CIBR)

Últimas noticias sobre First Trust NASDAQ Cybersecurity ETF (NASDAQ:CIBR)

First Trust NASDAQ Cybersecurity ETF

Technology

Industrials

To achieve its investment objectives, The Nasdaq CTA Cybersecurity Index is designed to track the performance of companies engaged in the cybersecurity segment of the technology and industrials sectors. It includes companies primarily involved in the building, implementation, and management of security protocols applied to private and public networks, computers, and mobile devices in order to provide protection of the integrity of data and network operations.

Broadcom, Inc. (purchase Right At $290.00 Per Share) (5)

Crowdstrike Holdings Inc

Cisco Systems, Inc.

Palo Alto Networks Inc.

Infosys, Adr

Darktrace Plc

Thales S.A.

Gen Digital Inc

Leidos Holdings, Inc.

Booz Allen Hamilton Holding Corp.

WIIM

BABA

BIDU

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Shares of US-listed Chinese stocks are trading higher amid potential hopes of a China economic stimulus following Trump's election victory.

Macro Economic Events

News

Econ #s

Economics

Federal Reserve

DoubleLine Capital's Gundlach Says Looks To Me There Will Be Some Pressure On Interest Rates Particularly At The Long End Due To Election Results; Think Its Right To See The Trump Victory As Reducing The Odds Of Near-Term Recession Substantially; Too Early For Fed To Declare Victory On Inflation, But Could See It By March Or April

Needham analyst Ami Fadia maintains Revolution Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVMD#NASDAQ">RVMD</a>) with a Buy and raises the price target from $61 to $68.

Price Target

Analyst Ratings

RVMD

Needham Maintains Buy on Revolution Medicines, Raises Price Target to $68

HC Wainwright &amp; Co. analyst Yi Chen initiates coverage on Vivani Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VANI#NASDAQ">VANI</a>) with a Buy rating and announces Price Target of $3.

Initiation

VANI

HC Wainwright & Co. Initiates Coverage On Vivani Medical with Buy Rating, Announces Price Target of $3

Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) shares are trading higher by 6% to $44.85 this week following news of Donald Trump's victory in the <a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election">2024 U.S. presidential election</a>. The stock has otherwise pulled back roughly 1.2% Thursday afternoon following the The Federal Reserve&#8217;s decision to <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41820253/fed-cuts-interest-rates-to-lowest-since-february-2023-sticks-to-data-driven-path">lower interest rates</a> by 0.25 percentage points.
Trump's win, coupled with a Republican-controlled Senate, has generated optimism among investors for policies that could benefit major banks and boost the financial sector broadly.
What To Know: Analysts expect that Trump's <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41772701/trumps-historic-return-7-ways-his-second-term-could-impact-the-us-economy">proposed tax cuts</a> could lead to higher net profits for corporations, particularly large financial institutions, as they capitalize on lower tax rates. This potential increase in profitability has made Bank of America's stock more attractive to investors.
Trump's economic plan includes further relaxing financial regulations, following his previous efforts to ease provisions of the Dodd-Frank Act, which had imposed strict oversight on banks in the aftermath of the 2008 financial crisis. 
If further deregulation efforts materialize, Bank of America and other large banks may see reduced compliance costs and greater operational flexibility, enabling them to expand their lending activities and profit margins.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41820253/fed-cuts-interest-rates-to-lowest-since-february-2023-sticks-to-data-driven-path">Fed Cuts Interest Rates To Lowest Since February 2023, Sticks To Data-Driven Path</a>
What Else: Trump's plan to stimulate the economy through infrastructure spending could also increase demand for financing and investment services. As one of the largest U.S. banks, Bank of America stands to benefit from a stronger domestic economy, which could drive loan growth and improve credit conditions. 
Furthermore, Trump's trade policies, while potentially inflationary, may encourage capital flows into the U.S. banking sector, as firms look for stable financing amid global market shifts.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41819318/nasdaq-100-extends-record-levels-ahead-of-fed-meeting-tesla-hits-26-month-highs-small-caps">Nasdaq 100 Extends Record Levels Ahead Of Fed Meeting, Tesla Hits 26-Month Highs, Small Caps Stall: What&#8217;s Driving Markets Thursday?</a>
<h2 class="wp-block-heading">How To Buy BAC Stock</h2>
By now you're likely curious about how to participate in the market for Bank of America &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so. 
In the the case of Bank of America, which is trading at $44.71 as of publishing time, $100 would buy you 2.24 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, BAC has a 52-week high of $45.55 and a 52-week low of $27.34.

What's Going On With Bank Of America (BAC) Shares

HC Wainwright &amp; Co. analyst Yi Chen maintains Regenxbio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>) with a Buy and raises the price target from $39 to $40.

RGNX

HC Wainwright & Co. Maintains Buy on Regenxbio, Raises Price Target to $40

HC Wainwright &amp; Co. analyst Robert Burns maintains Revolution Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVMD#NASDAQ">RVMD</a>) with a Buy and raises the price target from $62 to $64.

HC Wainwright & Co. Maintains Buy on Revolution Medicines, Raises Price Target to $64

In the current session, the stock is trading at $173.19, after a 0.78% increase. Over the past month, Expedia Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) stock increased by 14.80%, and in the past year, by 45.93%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2024/1731011414_0.png" alt="Past Year Chart" />

<h3>Expedia Group P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Expedia Group has a lower P/E than the aggregate P/E of 33.63 of the Hotels, Restaurants &amp; Leisure industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1731011414_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

EXPE

A Look Into Expedia Group Inc's Price Over Earnings

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth reiterates Janux Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JANX#NASDAQ">JANX</a>) with a Buy and maintains $63 price target.

Reiteration

JANX

HC Wainwright & Co. Reiterates Buy on Janux Therapeutics, Maintains $63 Price Target

Alibaba Group Holding Ltd &#8211; ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) shares are trading higher by 4.14% to $100.75 Thursday afternoon amid hopes of <a href="https://www.benzinga.com/government/24/11/41806635/whats-going-on-with-us-listed-chinese-stocks-like-alibaba-jd-nio-on-thursday">economic stimulus from China</a> following President-elect Donald Trump's win.
Trump's campaign promise to raise tariffs on Chinese imports up to 60% threatens to disrupt trade and trim China's GDP by one percentage point, leading Beijing to consider significant fiscal measures to support its economy.
What To Know: With the National People's Congress meeting this week, analysts expect a stimulus package potentially exceeding 10 trillion yuan ($1.39 billion), aimed at local government debt and real estate. 
For Alibaba, China's largest e-commerce and cloud company, stimulus could provide a crucial lift amid slowing consumer spending and domestic economic uncertainty. 
Enhanced financial support would likely increase consumer purchasing power, directly benefiting Alibaba's core e-commerce revenue and affiliated services like Alipay.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41814589/why-trumps-boost-to-treasury-yields-inflation-expectations-may-weaken-feds-efforts-">Why Trump&#8217;s Boost To Treasury Yields, Inflation Expectations May Weaken Fed&#8217;s Efforts To Cut Interest Rates</a>
What Else: Alibaba's gains Thursday reflect investor optimism that economic support will stabilize China's economy and offset potential losses from rising U.S. tariffs. As consumers regain confidence and spending power, Alibaba stands to benefit across its business lines, from retail to cloud computing.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41820253/fed-cuts-interest-rates-to-lowest-since-february-2023-sticks-to-data-driven-path">Fed Cuts Interest Rates To Lowest Since February 2023, Sticks To Data-Driven Path</a>
<h2 class="wp-block-heading">How To Buy BABA Stock</h2>
By now you're likely curious about how to participate in the market for Alibaba &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so. 
In the the case of Alibaba, which is trading at $100.61 as of publishing time, $100 would buy you 0.99 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, BABA has a 52-week high of $117.82 and a 52-week low of $66.63.

Why Alibaba Shares Are Rising

Needham analyst Scott Berg maintains Klaviyo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVYO#NYSE">KVYO</a>) with a Buy and raises the price target from $40 to $46.

KVYO

Needham Maintains Buy on Klaviyo, Raises Price Target to $46

USDAUD

USDCAD

USDEUR

USDGBP

USDJPY

The US dollar is lower against several other currencies after the Fed cut rates.

DoubleLine Capital's Jeffrey Gundlach Says We Recommend Investors Stay In The Intermediate Part Of The Treasury Bond Market; Believe If We Keep The Price Of Oil Around Low 70s, We Are Going To See Headline Inflation Below 2% In 4-5 Months

Needham analyst Joshua Reilly reiterates HubSpot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) with a Buy and maintains $730 price target.

HUBS

Needham Reiterates Buy on HubSpot, Maintains $730 Price Target

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) with a Buy and maintains $120 price target.

CYTK

HC Wainwright & Co. Reiterates Buy on Cytokinetics, Maintains $120 Price Target

DoubleLine Capital's Jeffrey Gundlach Says Not Positive On Long-Term Treasury Bonds

Shares of Enphase Energy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>), a leading solar energy technology provider, have fallen 17% this week amid a series of <a href="https://www.benzinga.com/quote/ENPH/earnings">analyst rating updates</a>.
Donald Trump&#8217;s re-election and GOP congressional gains signal a potential shift away from the renewable energy incentives that have bolstered the industry.
What To Know: Enphase Energy has thrived in recent years due to favorable federal and state policies promoting green energy, including tax credits that make solar systems more affordable for homeowners and businesses. 
The company has benefited from the extension of the federal solar investment tax credit and the broader clean energy policies of the Biden administration, which aligned with investor expectations for a sustained green transition. However, Trump's new term, alongside GOP legislative support, could jeopardize these subsidies.
A central component of <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41784504/trumps-win-sends-indices-to-record-highs-financials-small-caps-surge-bitcoin-tops-75-000-w">Trump's economic platform</a> is repealing various green energy tax credits, including those for solar installations, which could directly impact Enphase's core customer base. Trump has argued that these incentives distort the energy market and intends to prioritize tax breaks for fossil fuel production instead.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41814589/why-trumps-boost-to-treasury-yields-inflation-expectations-may-weaken-feds-efforts-">Why Trump&#8217;s Boost To Treasury Yields, Inflation Expectations May Weaken Fed&#8217;s Efforts To Cut Interest Rates</a>
This policy shift could result in reduced demand for solar installations if tax credits are repealed, as consumers and businesses may find it less financially viable to invest in solar energy without government assistance.
What Else: Trump&#8217;s proposed economic approach also includes rolling back environmental regulations, which could favor traditional energy sectors over renewables.
With the Republican-led Congress expected to support these policies, the likelihood of favorable conditions for fossil fuels has increased, raising concerns about competition within the energy sector.
Analysts also warn that a potential increase in trade tariffs could hurt Enphase's supply chain. Trump has committed to reimposing high tariffs on Chinese goods and implementing a 10% universal tariff on all imports.
Enphase, which sources components globally to keep production costs low, could see rising material costs under these tariffs. Higher costs would likely compress margins and challenge Enphase's pricing power, potentially making it harder to compete with fossil fuel energy sources whose production may become relatively cheaper.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41820253/fed-cuts-interest-rates-to-lowest-since-february-2023-sticks-to-data-driven-path">Fed Cuts Interest Rates To Lowest Since February 2023, Sticks To Data-Driven Path</a>
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, ENPH has a 52-week high of and a 52-week low of

ENPH

Why Enphase Energy (ENPH) Shares Are Falling

HC Wainwright &amp; Co. analyst Matthew Caufield reiterates LENZ Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LENZ#NASDAQ">LENZ</a>) with a Buy and maintains $38 price target.

LENZ

HC Wainwright & Co. Reiterates Buy on LENZ Therapeutics, Maintains $38 Price Target

DoubleLine Capital's Jeffrey Gundlach Says Probably Have One More Rate Cut Coming In Dec

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Celldex Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDX#NASDAQ">CLDX</a>) with a Buy and maintains $80 price target.

CLDX

HC Wainwright & Co. Reiterates Buy on Celldex Therapeutics, Maintains $80 Price Target

Investing in cybersecurity ETFs offers a strategic way to access a rapidly growing market driven by increasing digital threats, stricter regulations, and IoT expansion. Therefore, considering ETFs like Global X Cybersecurity (BUG), iShares Cybersecurity and Tech (IHAK), and First Trust NASDAQ Cybersecurity (CIBR) could be a wise choice for investors as digital threats continue to rise. Read more... The rising frequency of target-based attacks is driving strong demand for cybersecurity solutions, making the sector a key growth area. As digital threats increase, investing in cybersecurity ETFs is a strategic choice. Therefore, investors might consider buying top cybersecurity ETFs: Global X Cybersecurity ETF (<a href="https://stocknews.com/stock/BUG/">BUG</a>), iShares Cybersecurity and Tech ETF (<a href="https://stocknews.com/stock/IHAK/">IHAK</a>), and First Trust NASDAQ Cybersecurity ETF (<a href="https://stocknews.com/stock/CIBR/">CIBR</a>).
In today's digital economy, stricter government regulations and expanding IoT trends heighten the need for robust cybersecurity. The rise of cloud adoption demands scalable security, while AI-driven cyberattacks call for advanced countermeasures. Additionally, increased workplace device usage requires strong endpoint protection, further fueling the demand for comprehensive cybersecurity solutions.
With rising security demands across sectors like finance, manufacturing, automotive, healthcare, and data, driven by advanced threats like ransomware and deepfakes, the global cybersecurity market is projected to grow from $193.73 billion in 2024 to $562.72 billion by 2032 at a <a href="https://www.fortunebusinessinsights.com/industry-reports/cyber-security-market-101165">14.3% CAGR</a>. This strong growth trajectory presents promising investment opportunities in cybersecurity for the future.
Furthermore, cybersecurity ETFs offer diversified exposure to top companies in the sector, reducing the risk of investing in individual stocks while simplifying portfolio management. With this promising outlook, let's dive into the top three <a href="https://stocknews.com/category/technology-equities-etfs/">Technology Equities ETFs</a>, starting with number three.
ETF #3: Global X Cybersecurity ETF (<a href="https://stocknews.com/stock/BUG/">BUG</a>)
BUG is an exchange-traded fund launched and managed by Global X Management Company LLC. It invests globally in public equity markets, focusing on companies that develop and manage security protocols to prevent intrusions on systems, networks, applications, computers, and mobile devices, known as cybersecurity companies. It targets the information technology sector, investing in growth and value stocks across various market capitalizations. BUG seeks to track the performance of the Indxx Cybersecurity Index using a full replication technique.
With $787.70 million in AUM, the fund has a total of 23 holdings. BUG's top holding is Check Point Software Technologies Ltd. (<a href="https://stocknews.com/stock/CHKP/">CHKP</a>) with an 8.19% weighting, followed by Fortinet, Inc. (<a href="https://stocknews.com/stock/FTNT/">FTNT</a>), with a 7.41% weighting, and Palo Alto Networks, Inc. (<a href="https://stocknews.com/stock/PANW/">PANW</a>) with 7.33%.
BUG has an expense ratio of 0.50%, lower than the category average of 0.58%. It currently has a <a href="https://www.investopedia.com/terms/n/nav.asp">NAV</a> of $32.33. Its fund outflows came in at $3.37 million over the past month.
BUG has gained 10.3% year-to-date and 34.4% over the past year to close the last trading session at $32.33.
BUG's strong outlook is reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The ETF has an overall rating of A, translating to a Strong Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
It has an A grade for Buy &amp; Hold and Trade. Of the 119 ETFs in the B-rated <a href="https://stocknews.com/category/technology-equities-etfs/">Technology Equities ETFs</a> group, it is ranked #26. <a href="https://stocknews.com/stock/BUG/">Click here</a> to access all of BUG's POWR Ratings.
ETF #2: iShares Cybersecurity and Tech ETF (<a href="https://stocknews.com/stock/IHAK/">IHAK</a>)
IHAK is an exchange-traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors and invests in public equity markets worldwide. The fund focuses on stocks of companies operating in information technology and cybersecurity, including hardware, software, products, and services. It invests in both growth and value stocks across diversified market capitalizations and seeks to track the performance of the NYSE FactSet Global Cyber Security Index using a representative sampling technique.
With $912 million in assets under management (AUM), IHAK's top holding is SentinelOne, Inc. (<a href="https://stocknews.com/stock/S/">S</a>) with a 5.59% weighting, followed by Varonis Systems, Inc. (<a href="https://stocknews.com/stock/VRNS/">VRNS</a>), with a 5.17% weighting, and FTNT, with 5.13%. It has a total of 34 holdings.
It has an expense ratio of 0.47%, lower than the category average of 0.58%. It currently has a NAV of $50.33. IHAK's fund inflows came in at $133.88 million over the past year.
IHAK has gained 29.5% over the past year and 11.9% over the past six months to close the last trading session at $50.47.
IHAK's POWR Ratings reflect this promising outlook. The IHAK's overall A rating equates to a Strong Buy in our proprietary rating system.
IHAK has an A grade for Buy &amp; Hold and Trade. It is ranked #22 in the same group. To access all the POWR Ratings for IHAK, <a href="https://stocknews.com/stock/IHAK/">click here</a>.
ETF #1: First Trust NASDAQ Cybersecurity ETF (<a href="https://stocknews.com/stock/CIBR/">CIBR</a>)
CIBR is an exchange-traded fund launched and managed by First Trust Advisors LP. It invests in public equity markets worldwide, focusing on stocks of companies operating in information technology, software and services, and technology hardware and equipment sectors. The fund targets both growth and value stocks across diversified market capitalizations and seeks to track the performance of the NASDAQ CTA Cybersecurity Index using a full replication technique.
With $6.94 billion in assets under management (AUM), CIBR's top holding is CrowdStrike Holdings, Inc. Class A (<a href="https://stocknews.com/stock/CRWD/">CRWD</a>) with an 8.74% weighting, followed by Broadcom Inc. (<a href="https://stocknews.com/stock/AVGO/">AVGO</a>), with an 8.43% weighting, and Cisco Systems, Inc. (<a href="https://stocknews.com/stock/CSCO/">CSCO</a>), with 8.12%. CIBR has a total of 33 holdings.
CIBR has an expense ratio of 0.59%, higher than the category average of 0.58%. It currently has a NAV of $39.83. Its fund inflows came in at $139.92 million over the past year.
The ETF pays an annual dividend of $0.27, which yields 0.43% on the current price. It has a four-year average dividend yield of 0.51%. Its dividend payouts have increased at a CAGR of 64.4% over the past three years and 34% over the past five years.
CIBR has gained 35.9% over the past year and 16.2% over the past nine months to close the last trading session at $62.58.
CIBR's POWR Ratings reflect its promising prospects. The ETF's overall A rating equates to a Strong Buy in our proprietary rating system.
CIBR has an A grade for Buy &amp; Hold, Peer, and Trade. In the Technology Equities ETFs group, it is ranked #6. <a href="https://stocknews.com/stock/CIBR/">Click here</a> to access all of CIBR's POWR Ratings.
What To Do Next?
43 year investment veteran, Steve Reitmeister, has just released his 2024 market outlook along with trading plan and top 11 picks for the year ahead.
<a href="https://report.stocknews.com/sign-up/stock-market-outlook-2024/?formplacement=artbotad_smo24_rep">2024 Stock Market Outlook &gt;</a>

<hr />
CIBR shares were trading at $62.04 per share on Tuesday afternoon, down $0.54 (-0.86%). Year-to-date, CIBR has gained 15.44%, versus a 23.01% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Abhishek Bhuyan</h2> <img src='https:/wp-content/uploads/2023/07/ABhuyan.jpg' style="float:left; padding:5px;width:125px;">Abhishek embarked on his professional journey as a financial journalist due to his keen interest in discerning the fundamental factors that influence the future performance of financial instruments.<a href="https://stocknews.com/authors/?author=abhishek-bhuyan">More...</a>The post <a href=https://stocknews.com/news/cibr-ihak-bug-3-cybersecurity-etfs-to-buy-as-digital-threats-multiply/>3 Cybersecurity ETFs to Buy as Digital Threats Multiply</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

Comments

First Trust NASDAQ Cybersecurity ETF

Noticias

Últimas noticias sobre First Trust NASDAQ Cybersecurity ETF (NASDAQ:CIBR)

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL